[{"Assets_0_FY_USD":4933352000.0,"CommonStockSharesOutstanding_0_FY_shares":221084433.0,"EarningsPerShareBasic_4_FY_USD":4.3,"EarningsPerShareDiluted_4_FY_USD":4.27,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":749488000.0,"NetIncomeLoss_4_FY_USD":948581000.0,"ProfitLoss_4_FY_USD":948581000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":2986267000.0,"Revenues_4_FY_USD":2986267000.0,"StockholdersEquity_0_FY_USD":3770004000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":222074000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":220428000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20220208"}]